The DOI matches its Crossref record; 169 of the 169 references it cites were found in a registry or an index.
Nicotinic receptors in the brain. Links between molecular biology and behavior
Open accessAbstract
Molecular cloning has elucidated the sequence of a family of acetylcholine receptor subunits that are activated by nicotine. Subsequent studies on the localization of individual subunits and the physiological properties of nicotinic subunit combinations in vitro, have led to identification of subunit compositions of nicotinic receptors that may function in vivo, as the native receptor. A particular challenge for the field has been to use these molecular data to determine which individual nicotinic receptor subtype is responsible for mediating each of the behavioral effects of nicotine. Human and animal studies have shown that nicotine is reinforcing and likely responsible for the addictive properties of tobacco. In addition, nicotine has been shown to have effects on locomotion, cognition, affect, and pain sensitivity. Recent studies combining the techniques of molecular biology, pharmacology, electrophysiology, and behavioral analysis to analyze knock out mice that lack individual subunits of the nicotinic acetylcholine receptor, have helped identify the role of specific nicotinic subunits in some of these complex behaviors. These studies could ultimately be useful in designing specific nicotinic receptor agonists and antagonists that may have uses in the clinic.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“ACh signals through two classes of receptors: metabotropic muscarinic receptors (mAChRs) and ionotropic nicotinic receptors (nAChRs) (reviewed in (Picciotto et al., 2000; Wess, 2003a)).”
From Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior (2012) · cites this paper as Picciotto et al., 2000
Citations
Cites
Drugs of abuse: anatomy, pharmacology and function of reward pathways
Koob, G. F. (1992) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(92)90060-j · Cited by 2,070
McEwen, B. S., & Sapolsky, R. M. (1995) · Current Opinion in Neurobiology · doi:10.1016/0959-4388(95)80028-x · Cited by 1,889
Séguéla, P., Wadiche, J. I., Dineley‐Miller, K., Dani, J., & Jw, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-02-00596.1993 · Cited by 1,471
CENTRAL CHOLINERGIC SYSTEMS AND COGNITION
Everitt, B. J., & Robbins, T. W. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.649 · Cited by 1,348
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320
Self-citationLinkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus
Freedman, R., Coon, H., Myles-Worsley, M., Orr-Urtreger, A., Olincy, A., Davis, A., Polymeropoulos, M., Holik, J., Hopkins, J., Hoff, M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.587 · Cited by 1,141
Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors
McGehee, D. S., Heath, M. J. S., Gelber, S., Devay, P., & Role, L. W. (1995) · Science · doi:10.1126/science.7569895 · Cited by 1,070
The Diversity of Neuronal Nicotinic Acetylcholine Receptors
Sargent, P. B. (1993) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.16.030193.002155 · Cited by 1,052
Wada, E., Wada, K., Boulter, J., Deneris, E. S., Heinemann, S., Patrick, J., & Swanson, L. W. (1989) · The Journal of Comparative Neurology · doi:10.1002/cne.902840212 · Cited by 1,044
Hippocampal synaptic transmission enhanced by low concentrations of nicotine
Gray, R. G. F., Rajan, A. S., Radcliffe, K. A., Yakehiro, M., & Dani, J. A. (1996) · Nature · doi:10.1038/383713a0 · Cited by 947
Cited by
Sorted by citations
Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior
Picciotto, M. R., Higley, M. J., & Mineur, Y. S. (2012) · Neuron · doi:10.1016/j.neuron.2012.08.036 · Cited by 1,404
Neuronal nicotinic receptors: from structure to pathology
Gotti, C., & Clementi, F. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.09.006 · Cited by 970
Lou, X., Chen, G., Yan, L., Ma, J. Z., Zhu, J., Elston, R. C., & Li, M. D. (2007) · The American Journal of Human Genetics · doi:10.1086/518312 · Cited by 564
Millan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 569
Cigarette smoking and depression: tests of causal linkages using a longitudinal birth cohort
Boden, J. M., Fergusson, D. M., & Horwood, L. J. (2010) · British Journal of Psychiatry · doi:10.1192/bjp.bp.109.065912 · Cited by 477
Effects of nicotinic stimulation on cognitive performance
NEWHOUSE, P. A. (2003) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2003.11.001 · Cited by 411
Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia
Martin, L., Kem, W., & Freedman, R. (2004) · Psychopharmacology · doi:10.1007/s00213-003-1750-1 · Cited by 341
Towards a muscarinic hypothesis of schizophrenia
Raedler, T. J., Bymaster, F. P., Tandon, R., Copolov, D., & Dean, B. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001924 · Cited by 298
Millan, M. J. (2005) · Therapies · doi:10.2515/therapie:2005065 · Cited by 296
Nicotinic acetylcholine receptors as targets for antidepressants
Shytle, R. D., Silver, A. A., Lukas, R. J., Newman, M. B., Sheehan, D. V., & Sanberg, P. R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001035 · Cited by 279
Memantine for Alzheimer’s Disease: An Updated Systematic Review and Meta-analysis
Kishi, T., Matsunaga, S., Oya, K., Nomura, I., Ikuta, T., & Iwata, N. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170424 · Cited by 259
Castañé, A., Valjent, E., Ledent, C. A., Parmentier, M., Maldonado, R. J., & Valverde, O. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00118-1 · Cited by 242
Barr, R. S., Maravić, M. C., Jubelt, L. E., Mufti, R. S., Dyer, M. A., Weiss, A. P., Deckersbach, T., Kelly, J. F., Freudenreich, O., GOFF, D. C., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301423 · Cited by 242
Picciotto, M. R., Caldarone, B. J., Brunzell, D. H., Zachariou, V., Stevens, T. R., & King, S. L. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00161-9 · Cited by 221
Self-citationBodnar, A. L., Cortes-Burgos, L. A., Cook, K. K., Dinh, D. M., Groppi, V. E., Hajós, M., Higdon, N. R., Hoffmann, W. E., Hurst, R. S., Myers, J. K., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049363q · Cited by 216
Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission
Müller, N., & Schwarz, M. (2006) · Neurotoxicity Research · doi:10.1007/bf03033242 · Cited by 212
Ross, S. A., Wong, J. Y. F., Clifford, J. J., Kinsella, A., Massalas, J. S., Horne, M. K., Scheffer, I. E., Kola, I., Waddington, J. L., Berkovic, S. F., et al. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-17-06431.2000 · Cited by 204
Nicotinic modulation of neuronal networks: from receptors to cognition
Mansvelder, H. D., van Aerde, K. I., Couey, J. J., & Brussaard, A. B. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0070-z · Cited by 202
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/0269881104047273 · Cited by 203
Neuromodulation by acetylcholine: examples from schizophrenia and depression
Higley, M. J., & Picciotto, M. R. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.06.004 · Cited by 184
Pharmacodynamics of Memantine: An Update
Parsons, C. G., Rammes, G., & Danysz, W. (2008) · Current Neuropharmacology · doi:10.2174/157015908783769671 · Cited by 194
Endocannabinoid influence in drug reinforcement, dependence and addiction-related behaviors
Serrano, A., & Parsons, L. H. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.06.005 · Cited by 188
Current pharmacological treatments for nicotine dependence
George, T. P., & O’Malley, S. S. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.11.003 · Cited by 179
Forster, G. L., & Blaha, C. D. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02511.x · Cited by 175
Nicotinic Acetylcholine Receptors of Muscles and Nerves
Lindstrom, J. M. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1254.007 · Cited by 176
Central Nicotinic Receptors: Structure, Function, Ligands, and Therapeutic Potential
Romanelli, M., Gratteri, P., Guandalini, L., Martini, E., Bonaccini, C., & Gualtieri, F. (2007) · ChemMedChem · doi:10.1002/cmdc.200600207 · Cited by 171
Miwa, J. M., Stevens, T. R., King, S. L., Caldarone, B. J., Ibanez-Tallon, I., Xiao, C., Fitzsimonds, R. M., Pavlides, C., Lester, H. A., Picciotto, M. R., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.07.025 · Cited by 154
DNA methylation impacts on learning and memory in aging
Liu, L., van Groen, T., Kadish, I., & Tollefsbol, T. O. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.07.020 · Cited by 152
Williams, M. E., Burton, B., Urrutia, A., Shcherbatko, A., Chavez-Noriega, L. E., Cohen, C. J., & Aiyar, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410039200 · Cited by 152
Nicotine self‐medication of cognitive‐attentional processing
Evans, D. E., & Drobes, D. J. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00130.x · Cited by 152
Withdrawal from Chronic Nicotine Administration Impairs Contextual Fear Conditioning in C57BL/6 Mice
Davis, J. A., James, J. R., Siegel, S. J., & Gould, T. J. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2853-05.2005 · Cited by 146
Cholinergic circuits in cognitive flexibility
Prado, V. F., Janíčková, H., Al‐Onaizi, M., & Prado, M. A. M. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.09.013 · Cited by 158
Genetics of nicotinic acetylcholine receptors: Relevance to nicotine addiction
Mineur, Y. S., & Picciotto, M. R. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.06.010 · Cited by 139
The role of nicotinic acetylcholine receptors in the mechanisms of anesthesia
TASSONYI, E., Charpantier, E., Müller, D., Dumont, L., & Bertrand, D. (2002) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00740-7 · Cited by 131
Rabenstein, R. L., Caldarone, B. J., & Picciotto, M. R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0568-z · Cited by 129
Nicotine and Nicotinic Receptors; Relevance to Parkinson’s Disease
Quik, M., & Kulak, J. M. (2002) · NeuroToxicology · doi:10.1016/s0161-813x(02)00036-0 · Cited by 129
Smoking cessation: Progress, priorities, and prospectus.
NIAURA, R. S., & Abrams, D. B. (2002) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.70.3.494 · Cited by 121
Balerio, G. N., Aso, E., Berrendero, F., Murtra, P., & Maldonado, R. J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03714.x · Cited by 118
Vulnerability of125I-α-Conotoxin MII Binding Sites to Nigrostriatal Damage in Monkey
Quik, M., Polonskaya, Y., Kulak, J. M., & McIntosh, J. M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-15-05494.2001 · Cited by 109
Toyohara, J., & Hashimoto, K. (2010) · The Open Medicinal Chemistry Journal · doi:10.2174/1874104501004010037 · Cited by 109
Nicotine and cannabinoids: parallels, contrasts and interactions
VIVEROS, M., MARCO, E., & FILE, S. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2006.08.002 · Cited by 106
Hindocha, C., Freeman, T. P., Xia, J., Shaban, N. D. C., & Curran, H. V. (2017) · Psychological Medicine · doi:10.1017/s0033291717001222 · Cited by 105
Wehner, J. M., Keller, J. J., Keller, A. B., Picciotto, M. R., Paylor, R. E., Booker, T. K., Beaudet, A. L., Heinemann, S., & Balogh, S. A. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.016 · Cited by 105
Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice
Balerio, G. N., Aso, E., & Maldonado, R. J. (2006) · Psychopharmacology · doi:10.1007/s00213-005-0251-9 · Cited by 104
Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia
Martin-Ruiz, C. M., Haroutunian, V. H., Long, P., Young, A. H., Davis, K. L., Perry, E. K., & Court, J. A. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00348-2 · Cited by 100
Gulisano, W., Melone, M., Ripoli, C., Tropea, M. R., Li Puma, D. D., Giunta, S., Cocco, S., Marcotulli, D., Origlia, N., Palmeri, A., et al. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.0163-19.2019 · Cited by 100
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
Hyde, T. M., & Crook, J. M. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00101-6 · Cited by 97
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
Sacco, K. A., Bannon, K. L., & George, T. P. (2004) · Journal of Psychopharmacology · doi:10.1177/026988110401800403 · Cited by 100
Wing, V. C., Wass, C., Soh, D. W., & George, T. P. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06261.x · Cited by 99
Antinociceptive effects of choline against acute and inflammatory pain
Wang, Y., Su, D., Wang, R.-H., Liu, Y., & Wang, H. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.026 · Cited by 99
Walker, D. P., Wishka, D. G., Piotrowski, D. W., Jia, S., Reitz, S. C., Yates, K. M., Myers, J. K., Vetman, T. N., Margolis, B. J., Jacobsen, E. J., et al. (2006) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2006.09.019 · Cited by 95
Schmaal, L., Berk, L., Hulstijn, K. P., Cousijn, J., Wiers, R. W., & van den Brink, W. (2011) · European Addiction Research · doi:10.1159/000327682 · Cited by 93
Regulation of neuronal nicotinic receptor traffic and expression
Gaimarri, A., Moretti, M., Riganti, L., Zanardi, A., Clementi, F., & Gotti, C. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.02.005 · Cited by 89
Vázquez-Palacios, G., Bonilla‐Jaime, H., & Velázquez‐Moctezuma, J. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.03.002 · Cited by 89
Beneficial metabolic effects of M3 muscarinic acetylcholine receptor deficiency
Gautam, D., Gavrilova, O., Jeon, J., Pack, S., Jou, W., Cui, Y., Li, J. H., & Wess, J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.09.008 · Cited by 90
Electronic Cigarette Use and the Risk of Cardiovascular Diseases
Espinoza-Derout, J., Shao, X. M., Lao, C. J., Hasan, K. M., Rivera, J. C., Jordan, M. C., Echeverria, V., Roos, K. P., Sinha-Hikim, A. P., & Friedman, T. C. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.879726 · Cited by 103
Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum
Graham, A., COURT, J. A., Martin-Ruiz, C. M., Jaros, E., Perry, R., Volsen, S. G., Bose, S., Evans, N. M., Ince, P. G., Kuryatov, A., et al. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00223-3 · Cited by 85
Pogocki, D., Ruman, T., Danilczuk, M., Danilczuk, M., Celuch, M., & Wałajtys-Rode, E. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.02.038 · Cited by 84
Differential nicotinic acetylcholine receptor subunit expression in the human hippocampus
Graham, A. J., Ray, M. A., Perry, E. K., Jaros, E., Perry, R. H., Volsen, S. G., Bose, S., Evans, N. M., Lindstrom, J. M., & COURT, J. A. (2003) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(02)00100-x · Cited by 85
Would smokers with schizophrenia benefit from a more flexible approach to smoking treatment?
McChargue, D. E., Gulliver, S. B., & Hitsman, B. L. (2002) · Addiction · doi:10.1046/j.1360-0443.2002.00064.x · Cited by 83
Barros, D. M., Ramirez, M. R., dos Reis, E. A., & Izquierdo, I. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.03.010 · Cited by 81
Endocannabinoid Regulation of Acute and Protracted Nicotine Withdrawal: Effect of FAAH Inhibition
Cippitelli, A., Astarita, G., Duranti, A., Caprioli, G., Ubaldi, M., Stopponi, S., Kallupi, M., Sagratini, G., de Fonseca, F. R., Piomelli, D., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028142 · Cited by 81
Fergusson, D. M., Boden, J. M., & Horwood, L. J. (2010) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-010-0268-1 · Cited by 87
Positive and Negative Effects of Alcohol and Nicotine and Their Interactions: A Mechanistic Review
Hurley, L. L., Taylor, R. E., & Tizabi, Y. (2011) · Neurotoxicity Research · doi:10.1007/s12640-011-9275-6 · Cited by 83
de Castro, M. R., Ventura‐Lima, J., de Freitas, D. P. S., Valente, R. D. S., Dummer, N. S., Aguiar, R. B., dos Santos, L. C., Marins, L. F., Geracitano, L. A., Monserrat, J. M., et al. (2009) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2009.05.017 · Cited by 77
Nicotine Vaccines to Assist with Smoking Cessation
Raupach, T., Hoogsteder, P., & van Schayck, O. C. P. (2012) · Drugs · doi:10.2165/11599900-000000000-00000 · Cited by 76
Alzarea, S., & Rahman, S. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.03.019 · Cited by 75
Alterations in α4β2 nicotinic receptors in cognitive decline in Alzheimer’s aetiopathology
Okada, H., Ouchi, Y., Ogawa, M., Futatsubashi, M., Saito, Y., Yoshikawa, E., Terada, T., Oboshi, Y., Tsukada, H., Ueki, T., et al. (2013) · Brain · doi:10.1093/brain/awt195 · Cited by 72
Trezza, V., Baarendse, P. J. J., & Vanderschuren, L. J. M. J. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2009.85 · Cited by 72
Huang, H., Xu, Y., & van den Pol, A. N. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00740.2010 · Cited by 70
Biological basis of tobacco addiction: Implications for smoking-cessation treatment
Jiloha, R. C. (2010) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.74303 · Cited by 75
Marco, E. M., Granstrem, O., Moreno, E., Llorente, R., Adriani, W., Giovanni Laviola, A., & Viveros, M. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.11.013 · Cited by 67
Cellular, molecular, and genetic substrates underlying the impact of nicotine on learning
Gould, T. J., & Leach, P. T. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.08.004 · Cited by 72
Extensive overlap of mu-opioid and nicotinic sensitivity in cortical interneurons
Ferezou, I., Hill, E. L., Cauli, B., Gibelin, N., Kaneko, T., Rossier, J., & Lambolez, B. (2007) · Cerebral Cortex · doi:10.1093/cercor/bhl104 · Cited by 65
Nicotine addiction and psychiatric disorders
Kutlu, M. G., Parikh, V., & Gould, T. J. (2015) · International Review of Neurobiology · doi:10.1016/bs.irn.2015.08.004 · Cited by 65
Rose, E. J., Ross, T. J., Salmeron, B. J., Lee, M., Shakleya, D. M., Huestis, M. A., & Stein, E. A. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.09.013 · Cited by 67
Associations of Variants in CHRNA5/A3/B4 Gene Cluster with Smoking Behaviors in a Korean Population
Li, M. D., Yoon, D., Lee, J., Han, B., Niu, T., Payne, T. J., Ma, J. Z., & Park, T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012183 · Cited by 66
Regulation of the Neuronal Nicotinic Acetylcholine Receptor by Src Family Tyrosine Kinases
Wang, K., Hackett, J. T., Cox, M., van Hoek, M. L., Lindstrom, J. M., & Parsons, S. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309652200 · Cited by 64
Budzyńska, B., Boguszewska‐Czubara, A., Kruk-Słomka, M., Skalicka‐Woźniak, K., Michalak, A., Musik, I., Biała, G., & Głowniak, K. (2013) · Physiology & Behavior · doi:10.1016/j.physbeh.2013.08.019 · Cited by 65
Nicotine and Hippocampus-Dependent Learning: Implications for Addiction
Gould, T. J. (2006) · Molecular Neurobiology · doi:10.1385/mn:34:2:93 · Cited by 61
Nicotinic receptor involvement in antinociception induced by exposure to cigarette smoke
Simons, C. T., Cuéllar, J. M., Moore, J. A., Pinkerton, K. E., Uyeminami, D. L., Carstens, M. I., & Carstens, E. E. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.07.025 · Cited by 61
Li, M. D., Xu, Q., Lou, X., Payne, T. J., Niu, T., & Ma, J. Z. (2009) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31043 · Cited by 60
Impact of intravenous nicotine on BOLD signal response to photic stimulation
Jacobsen, L. K., Gore, J. C., Skudlarski, P., Lacadie, C., Jatlow, P. L., & Krystal, J. H. (2002) · Magnetic Resonance Imaging · doi:10.1016/s0730-725x(02)00494-0 · Cited by 60
Borghese, C. M. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.053710 · Cited by 58
Role of the endogenous cannabinoid system in nicotine addiction: novel insights
Gamaleddin, I. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00041 · Cited by 59
Alderson, H. L., Latimer, M. P., & Winn, P. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04737.x · Cited by 59
Kosowski, M., Smolarczyk, J., Hachuła, M., Maligłówka, M., Basiak, M., Machnik, G., Pudło, R., & Okopień, B. (2021) · Molecules · doi:10.3390/molecules26102838 · Cited by 60
Tobacco Influence on Taste and Smell: Systematic Review of the Literature
Ré, A. F. D., Gurgel, L. G., Buffon, G., Moura, W. E. R., Vidor, D. C. G. M., & Maahs, M. A. P. (2017) · International Archives of Otorhinolaryngology · doi:10.1055/s-0036-1597921 · Cited by 57
Nicotinic receptors and hippocampal synaptic plasticity…it’s all in the timing
McGehee, D. S. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)02127-5 · Cited by 53
Alzheimer's disease: the pharmacological pathway
Allain, H., Bentué‐Ferrer, D., Tribut, O., Gauthier, S. G., Michel, B., & Rochelle, C. D. L. (2003) · Fundamental and Clinical Pharmacology · doi:10.1046/j.1472-8206.2003.00153.x · Cited by 53
Neurobiological Determinants of Tobacco Smoking in Schizophrenia
Lucatch, A. M., Lowe, D. J. E., Clark, R. C., Kozak, K., & George, T. P. (2018) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00672 · Cited by 54
Shao, X. M., & Feldman, J. L. (2002) · Journal of Neurophysiology · doi:10.1152/jn.2002.88.4.1851 · Cited by 52
Brain Reward System Activity in Major Depression and Comorbid Nicotine Dependence
Cárdenas, L., Tremblay, L. K., Naranjo, C. A., Herrmann, N., Zack, M. H., & Busto, U. E. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.3.1265 · Cited by 51
Rodent models of treatment-resistant depression
Caldarone, B. J., Zachariou, V., & King, S. L. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.063 · Cited by 57
Virginio, C., Giacometti, A., Aldegheri, L., Rimland, J. M., & Terstappen, G. C. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01750-8 · Cited by 50
Vink, J. M., & Boomsma, D. I. (2002) · Biological Psychology · doi:10.1016/s0301-0511(02)00052-2 · Cited by 50
Gx-50 Inhibits Neuroinflammation via α7 nAChR Activation of the JAK2/STAT3 and PI3K/AKT Pathways
Shi, S., Liang, D., Bao, M., Xie, Y., Xu, W., Wang, L., Wang, Z., & Qiao, Z. (2016) · Journal of Alzheimer s Disease · doi:10.3233/jad-150963 · Cited by 50
Neuronal Nicotinic Receptor and Psychiatric Disorders: Functional and Behavioral Effects of Nicotine
Araki, H., Suemaru, K., & Gomita, Y. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.88.133 · Cited by 48
Barros, D., Ramirez, M., & Izquierdo, I. (2005) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2004.10.001 · Cited by 52
Tatsumi, R., Fujio, M., Satoh, H., Katayama, J., Takanashi, S.-I., Hashimoto, K., & Tanaka, H. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm049188d · Cited by 47
Metadata
- Authors
- Picciotto, M.
- Affiliations
- Yale University (US)
- Corresponding author
- Picciotto, M
- ORCID
- Picciotto, M
- Venue
- Neuropsychopharmacology
- Published
- 2000-05
- Volume
- 22
- Issue
- 5
- Pages
- 451-465
- ISSN
- 0893-133X (ISSN-L)
- OpenAlex
- W2091673195
- Cited by
- 354
- References
- 165
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 7 · 2022: 12 · 2021: 10 · 2020: 4 · 2019: 7 · 2018: 10 · 2017: 9 · 2016: 16 · 2015: 14 · 2014: 13 · 2013: 15 · 2012: 10
- FWCI
- 1.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health (DA10455)
- National Institute on Drug Abuse (DA-00167, DA 10455, DA-07290, K12DA000167)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nicotinic Acetylcholine Receptors Study
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- nicotinic acetylcholine receptors, nicotinic receptor subunits, nicotine, nicotine dependence, tobacco, receptor knockout mice, locomotion, cognition, affect, pain sensitivity
- MeSH terms
- Animals, Behavior, Humans, Models, Neurological, Molecular Biology, Receptors, Nicotinic, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review